Anything under a cheeky dollar this is a steal, page-7

Correct me if im wrong , but was there an In vitro study started late last year with QPS Neuro. regarding protein uptakes and degeneration levels aimed squarely at Alzheimers ? The pathway to validation regarding stroke is well documented but theres a few unknowns that could pop up at anytime regarding the other indicators (TBI, HIE Alz etc) Assuming we get some prelim safety data on stroke late Q2 , the next 6 months should be very interesting. Imo they have also in the meantime been getting the board in a position to do deals / avoid losing our value, you cant help but be optimistic looking forward